Meningococcal B (Bexsero) rollout 

Meningococcal B (Bexsero) rollout 

Kia ora koutou  

It was wonderful to see so many of you at Wednesday evening’s Meningococcal B vaccine implementation webinar. For those of you who may have missed it, it’s now available on IMAC’s website.  

Some great questions were asked, and IMAC will have a FAQ document available on their website from 1 March which provides answers to the key questions.   

From 1 March 2023 the Meningococcal B vaccine (Bexsero) will be funded for:   

Scheduled programme: No end date 

Scheduled programme: No end date 

  • Children aged up to 12 months
  • Administered as part of the Childhood Immunisation Programme at three months, five months, and a booster dose at 12 months.  
  • Can be offered at age eight weeks with the second dose at four months.  
  • Do not delay the six-week immunisations.  
  • People aged 13-25 in their first year of specified close living situations.  
  • Two doses funded.  

Catch-up programme: Ends 31 August 2025 

Catch-up programme: Ends 28 February 2024 

  • Children aged 13 months to 59 months. 
  • Up to three doses funded, depending on the age of the child when they have their first dose. 

All people aged 13-25 in specified close living situations. 

Two doses funded. 


Close living  

Close living is defined in the pharmaceutical schedule as individuals who are currently living in or entering their first year of boarding school hostels, tertiary education halls of residence, military barracks, or prisons. 

Catch-up programme age criteria 

As for all vaccines with an upper age limit – if the course is started before that age limit, then the funded course can be completed. For example, if a child has their first dose of Bexsero before their fifth birthday then they are eligible for the full course.   




Scheduled programmes 

  • All claims will be submitted as normal and will be accepted for any or all of the scheduled events. 

Catch-up programme  

  • Vaccinators are encouraged to offer catch up doses opportunistically to the eligible groups and claims for these will be accepted. 
  • We will work with Te Whatu Ora districts to understand planning and delivery models and determine resourcing requirements for catch-up programmes. 


Vaccine Ordering 


  • Orders can be placed now through ProPharma. 
  • There are no issues with supply. 
  • Bexsero will arrive in single dose packs. Be mindful of the additional fridge space required and also influenza vaccine requirements.  


Recording & Monitoring 


  • To enable Bexsero recording in your practice management system (PMS) from 1 March - you will need to enter this in the same way as for the current high-risk schedule for Meningococcal B. 
  • Your PMS vendor will provide further guidance on how to do this. 
  • The Programme is working with all PMS vendors to enable a full update of all schedules in the coming months – this is due to the large number of recent system updates required, including for PCV13 and Shingrix.  


  • No changes are able to made to the National Immunisation Register (NIR). The NIR can accept MenB vaccine but the schedules within NIR cannot be updated. 
  • This means consumer records will be updated but won’t be attached as part of the immunisation schedule.   


  • There is no change for process providers need to follow when entering directly into the Aotearoa Immunisation Register (AIR) as MenB vaccine is enabled in AIR. 


  • Once the full PMS update is completed, Men B vaccine will be included in recall messaging.  


  • Childhood milestone reporting will not include MenB at this time, which is is standard practice when new vaccines are introduced.  
  • The National Immunisation Programme is working with the districts on interim operational reporting options. 




  • Updated childhood resources for providers and whānau will be available through HealthEd from 1 March
  • The National Immunisation Programme is finalising a new childhood immunisation website aimed at consumers. It will be available in March The IMAC website includes further Bexsero guidance including administration of paracetamol. 


  • Updated resources focused on young people who meet the close-living criteria will be available from 1 March through the programme dropbox 

Immunisation Handbook 

  • The Immunisation Handbook will be updated to provide the best available clinical advice and recommendations.  
  • Just a reminder the Handbook is no longer available as a printed version, and only the online version should be used.  

Schedule Card 

  • The dose schedule chart (HE1308) that is commonly kept on the front of your vaccine fridge has been updated to include Bexsero and will sent out with vaccine deliveries. 


If you have any questions about this update, please email  

Ngā mihi  

Rachel Mackay  

Group Manager Operations  

National Immunisation Programme